Conclusion
UTI are common among patients with type 2 diabetes
mellitus. In these patients, UTI are more severe, caused by
more resistant pathogens, and is associated with worse outcomes
than in patients without diabetes. Treatment should
be offered only to symptomatic cases, as ASB is a common
finding, and antibiotic treatment in such cases serves mostly
to increase bacterial resistance. Treatment should be tailored
according to severity of infection and culture results. Further
studies are needed to improve the treatment of patients with
type 2 diabetes and UTI.
Disclosure
The authors report no conflicts of interest in this work.